Recombinant HIV1 p17 + p24 + gp120 protein is a Human immunodeficiency virus type 1 (NDK ISOLATE) Fragment protein, expressed in Escherichia coli and suitable for ELISA, WB.
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application ELISA | Reactivity Reacts | Dilution info - | Notes - |
Application WB | Reactivity Reacts | Dilution info - | Notes - |
Envelope glycoprotein gp160. Oligomerizes in the host endoplasmic reticulum into predominantly trimers. In a second time, gp160 transits in the host Golgi, where glycosylation is completed. The precursor is then proteolytically cleaved in the trans-Golgi and thereby activated by cellular furin or furin-like proteases to produce gp120 and gp41. Surface protein gp120. Attaches the virus to the host lymphoid cell by binding to the primary receptor CD4. This interaction induces a structural rearrangement creating a high affinity binding site for a chemokine coreceptor like CXCR4 and/or CCR5. Acts as a ligand for CD209/DC-SIGN and CLEC4M/DC-SIGNR, which are respectively found on dendritic cells (DCs), and on endothelial cells of liver sinusoids and lymph node sinuses. These interactions allow capture of viral particles at mucosal surfaces by these cells and subsequent transmission to permissive cells. HIV subverts the migration properties of dendritic cells to gain access to CD4+ T-cells in lymph nodes. Virus transmission to permissive T-cells occurs either in trans (without DCs infection, through viral capture and transmission), or in cis (following DCs productive infection, through the usual CD4-gp120 interaction), thereby inducing a robust infection. In trans infection, bound virions remain infectious over days and it is proposed that they are not degraded, but protected in non-lysosomal acidic organelles within the DCs close to the cell membrane thus contributing to the viral infectious potential during DCs' migration from the periphery to the lymphoid tissues. On arrival at lymphoid tissues, intact virions recycle back to DCs' cell surface allowing virus transmission to CD4+ T-cells. Transmembrane protein gp41. Acts as a class I viral fusion protein. Under the current model, the protein has at least 3 conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During fusion of viral and target intracellular membranes, the coiled coil regions (heptad repeats) assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and target cell membranes. Complete fusion occurs in host cell endosomes and is dynamin-dependent, however some lipid transfer might occur at the plasma membrane. The virus undergoes clathrin-dependent internalization long before endosomal fusion, thus minimizing the surface exposure of conserved viral epitopes during fusion and reducing the efficacy of inhibitors targeting these epitopes. Membranes fusion leads to delivery of the nucleocapsid into the cytoplasm.
gag, gag-pol
Envelope glycoprotein gp160, Env polyprotein, env
Recombinant HIV1 p17 + p24 + gp120 protein is a Human immunodeficiency virus type 1 (NDK ISOLATE) Fragment protein, expressed in Escherichia coli and suitable for ELISA, WB.
pH: 7.2 - 7.6
Preservative: 0.01% Sodium azide
Constituents: 50% Glycerol (glycerin, glycerine), 9% Urea, 0.395% Tris HCl, 0.0292% EDTA
Envelope glycoprotein gp160
Belongs to the HIV-1 env protein family.
Highly glycosylated by host. The high number of glycan on the protein is reffered to as 'glycan shield' because it contributes to hide protein sequence from adaptive immune system.
HIV-1 proteins p17 p24 and gp120 have essential roles in the lifecycle of the Human Immunodeficiency Virus Type 1 (HIV-1). The p17 protein also known as the matrix protein weighs approximately 17 kDa and contributes to viral particle assembly. The p24 protein or capsid protein with a mass of roughly 24 kDa forms the core structure of the virus encapsulating the viral RNA genome and associated enzymes. The gp120 is a glycoprotein found on the virus surface with a mass of about 120 kDa and facilitates viral entry by binding to CD4 receptors on host cells. These proteins are highly expressed in infected human T-cells macrophages and dendritic cells.
These proteins are fundamental in maintaining the structural integrity and infectivity of the HIV-1 virus. p17 ensures proper viral assembly and budding while p24 stabilizes the viral core both protecting the HIV-1 genome during replication. gp120 as part of the envelope protein complex with gp41 mediates entry of the virus by interacting with host cell receptors and co-receptors like CCR5 or CXCR4. This complex is important for the initial step in the viral replication cycle facilitating fusion of the viral and cellular membranes.
HIV-1 p17 p24 and gp120 interact with multiple host cellular pathways during infection particularly those related to immune response and cell death. The gp120 protein engages the CD4+ T-cell signaling pathway leading to immune system evasion by the virus through T-cell depletion. These proteins are also involved in the apoptotic pathway where gp120 can induce apoptosis in uninfected cells via bystander effects contributing to the progression of AIDS. Other proteins like gp41 and viral protease are connected through these pathways supporting viral replication and pathogenesis.
HIV-1 proteins p17 p24 and gp120 are intimately associated with the development of AIDS and chronic HIV infection. These proteins' interaction with immune cell receptors leads to progressive immunodeficiency. For instance gp120 binds to CD4 and its co-receptors crippling the host immune defense. Moreover the viral proliferation and immune cell depletion driven by these proteins are linked to opportunistic infections and HIV-associated neurocognitive disorders. gp120's relationship with other proteins such as Nef and Tat further influences disease progression through immune system modulation and increased viral replication.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com